Crossed rhythmic synaptic input to motoneurons during selective activation of the contralateral spinal locomotor network.
To investigate the cellular mechanisms underlying locomotor-related left-right coordination, we monitored the crossed synaptic input to lumbar motoneurons during contralateral ventral root rhythmicity in the neonatal rat spinal cord in vitro. Using a longitudinal split-bath setup, one hemicord was kept in normal solution, whereas the contralateral hemicord was exposed to 5-HT and NMDA. With this approach, rhythmic bursting could be induced in the ventral roots on the agonist-exposed side, whereas the ventral roots on the agonist-free side remained silent. Intracellular recordings were made from L1-L3 motoneurons on the silent agonist-free side during rhythmic activity in the contralateral ventral roots. At the resting membrane potential, the typical crossed synaptic input was a rhythmic barrage of depolarizing IPSPs. This input modulated the frequency of spikes induced with depolarizing direct current by inhibiting firing in phase with the contralateral bursts. Intracellular chloride loading increased the amplitude of the IPSPs, suggesting that they were chloride-dependent. Strychnine but not bicuculline generally blocked the rhythmic inhibitory input when added to the agonist-free side during contralateral rhythmicity. APV and CNQX on the agonist-free side abolished the rhythmic inhibitory input in most motoneurons but not in all. We suggest that rat spinal motoneurons receive a mainly glycinergic rhythmic inhibition from the contralateral half of the locomotor network. Unlike in simpler vertebrates, the crossed inhibition often appears to be at least disynaptic, involving inhibitory premotor neurons located on the same side as the receiving motoneurons. These premotor neurons are rhythmically excited via a crossed pathway that depends on glutamatergic transmission.
Kjaerulff
O
O
Division of Neurophysiology, Department of Medical Physiology, The Panum Institute, University of Copenhagen, DK-2200 Copenhagen, Denmark.
Kiehn
O
O
D015763:2-Amino-5-phosphonovalerate / Q000494:pharmacology; D018750:6-Cyano-7-nitroquinoxaline-2,3-dione / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D001640:Bicuculline / Q000494:pharmacology; D002712:Chlorides / Q000378:metabolism; D004594:Electrophysiology; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D018756:GABA Antagonists / Q000494:pharmacology; D005998:Glycine / Q000502:physiology; D018684:Glycine Agents / Q000494:pharmacology; D008124:Locomotion / Q000502:physiology*; D009046:Motor Neurons / Q000737:chemistry / Q000187:drug effects / Q000502:physiology*; D016202:N-Methylaspartate / Q000494:pharmacology; D009433:Neural Inhibition / Q000187:drug effects / Q000502:physiology; D010507:Periodicity; D051381:Rats; D017208:Rats, Wistar; D011963:Receptors, GABA-A / Q000502:physiology; D012701:Serotonin / Q000494:pharmacology; D013116:Spinal Cord / Q000737:chemistry / Q000166:cytology* / Q000502:physiology; D013126:Spinal Nerve Roots / Q000737:chemistry / Q000166:cytology / Q000502:physiology; D013331:Strychnine / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology*
D002712:Chlorides; D018690:Excitatory Amino Acid Agonists; D018691:Excitatory Amino Acid Antagonists; D018756:GABA Antagonists; D018684:Glycine Agents; D011963:Receptors, GABA-A; D012701:Serotonin; D016202:N-Methylaspartate; D018750:6-Cyano-7-nitroquinoxaline-2,3-dione; D015763:2-Amino-5-phosphonovalerate; D013331:Strychnine; D005998:Glycine; D001640:Bicuculline